Weight Loss Injections and ADHD: the Practical Picture

ADHD stimulant medicines such as methylphenidate and lisdexamfetamine already suppress appetite — combining them with a GLP-1 injection can amplify this effect and requires monitoring.
There is no UK regulatory bar on people with ADHD using licensed weight loss injections, but suitability is assessed individually by a prescriber, not by a checklist.
Irregular eating patterns common in ADHD can increase the risk of nausea and GI side effects during dose titration, practical meal-timing strategies can help.
Both Mounjaro and Wegovy are Black Triangle (▼) medicines under additional MHRA monitoring; any unexpected effects should be reported via the Yellow Card scheme.

If you have ADHD and are considering weight loss injections, there are a few specific things worth understanding before you start. GLP-1 medicines such as Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only treatments that require clinical assessment, and ADHD introduces some genuinely relevant questions — around appetite, medication interactions, and how the titration process tends to go. None of those questions are dealbreakers, but a prescriber needs the full picture. Here is what the evidence and UK clinical guidance currently say.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How ADHD interacts with GLP-1 weight loss injections at each stage of treatment

Step 1: Understanding the appetite overlap before your consultation

ADHD and obesity frequently occur together. Research consistently shows higher rates of obesity among adults with ADHD, partly because of impulsive eating, reward-driven food choices, and disrupted meal routines, not a lack of effort. That context matters when a prescriber is assessing you.

GLP-1 medicines work by slowing gastric emptying and reducing appetite signals. Stimulant ADHD medications, including methylphenidate (Ritalin, Concerta) and lisdexamfetamine (Vyvanse), suppress appetite through a different mechanism. When both are active at once, appetite can drop significantly. Some people find this helpful; others find eating enough protein and calories becomes genuinely difficult. Your prescriber will want to know which ADHD medicines you take, at what dose, and how your appetite already behaves on them. Being specific saves time. See our guide on weight loss injections and ADHD medication for a closer look at how these medicines sit alongside each other.

The NHS notes that these are prescription-only medicines requiring clinical assessment, and the NHS tirzepatide page lists the conditions and medicines your clinical team needs to know about before treatment begins. ADHD medication is one of them.

Step 2: The titration phase, why ADHD makes slow and steady especially important

Treatment starts at a low dose. Mounjaro begins at 2.5mg; the prescriber increases the dose once your system has settled, typically every four weeks. That pacing exists for a reason: GI side effects, chiefly nausea, constipation, and loose stools, are most common in the early weeks and tend to ease as your body adjusts.

For people with ADHD, irregular eating habits can make the GI phase harder. Skipping breakfast, eating one large meal in the evening, or forgetting to drink enough water during the day all increase the likelihood of nausea on a GLP-1. Building a loose meal structure during titration matters more than it might sound. Small, regular meals, adequate protein, and consistent hydration give the injection the best conditions to work in.

Some adults with ADHD also find that the cognitive load of managing a new injection routine, refrigeration, and weekly scheduling is easier with a prompt system: a phone alarm, a medication tracker app, or simply putting the pen in the fridge door where it can't be missed. That kind of practical scaffolding is worth setting up before the first injection, not after. For more on how weight loss injections work day to day, we cover the full routine.

Step 3: Monitoring and what to watch for during treatment

Once titration is underway, the main things to track are weight, appetite adequacy, and mood. Weight monitoring happens at every clinical re-review; our prescribers check in before each repeat order, not after it. Appetite adequacy is worth self-monitoring, if eating has become an afterthought and you are losing weight faster than expected, tell your prescriber. That matters on any GLP-1 treatment, but the combination with a stimulant makes it more likely.

Mood is worth mentioning too. Both ADHD and obesity independently affect mental health, and GLP-1 medicines carry a precautionary note around low mood and self-harm thoughts in the patient information leaflet. It is not a common effect, but it is one to be aware of and to flag to a clinician promptly if it arises. You can also report unexpected effects directly to the MHRA via the Yellow Card scheme, which monitors medicines under active surveillance.

On cost: how much weight loss injections cost is a reasonable thing to factor in early, since treatment is typically ongoing for months rather than weeks. Understanding the full picture before starting helps with planning.

Step 4: Getting assessed, what to bring to your consultation

A same-day clinical review is only as useful as the information it is based on. Before starting your consultation, make a note of your current ADHD medication name, dose, and how long you have been taking it. If your eating patterns are genuinely disrupted, whether meals are rushed, skipped, or very late in the day, say so. A prescriber who understands your actual routine can make a better clinical decision than one working from a generalised picture.

People with ADHD are, if anything, often more thoughtful about medication decisions than they get credit for, they have usually spent years navigating prescribing processes and monitoring their own responses. That self-awareness is useful in a consultation. Bring it.

Mounjaro and Wegovy are both licensed for adults with a BMI of 30 or above, or from 27 with a weight-related health condition. ADHD alone does not disqualify you. If you would like to understand the broader options before deciding, our weight loss treatment overview covers all available routes, and our weight loss injections page gives the full background on both licensed options, including a comparison of the 3 weight loss injections currently available. You can also read about getting injections through your GP if the NHS route is relevant to your situation. When you are ready, speak to our prescribers for a free consultation reviewed the same day by a GPhC-registered clinician, not a questionnaire bot.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions